Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
9.70
+0.80 (9.06%)
At close: Nov 4, 2026, 4:00 PM EST
9.57
-0.13 (-1.29%)
After-hours: Nov 4, 2026, 6:02 PM EST
Teladoc Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,468 | 2,530 | 2,570 | 2,602 | 2,407 | 2,033 | |
Revenue Growth | -2.38% | -1.54% | -1.26% | 8.13% | 18.41% | 85.81% |
Cost of Revenue | 775.67 | 771.59 | 751.27 | 760.03 | 743.99 | 650.26 |
Gross Profit | 1,692 | 1,758 | 1,818 | 1,842 | 1,663 | 1,382 |
Selling, General & Admin | 1,188 | 1,280 | 1,346 | 1,367 | 1,301 | 1,105 |
Research & Development | 267.88 | 277.92 | 307.27 | 348.52 | 333.63 | 311.88 |
Amortization of Goodwill & Intangibles | 358.59 | 350.76 | 363.37 | 325.93 | 234.72 | 195.3 |
Operating Expenses | 1,825 | 1,922 | 2,027 | 2,053 | 1,880 | 1,621 |
Operating Income | -132.33 | -163.4 | -208.79 | -210.5 | -217.47 | -238.99 |
Interest Expense | -20.36 | -19.71 | -23.8 | -22.28 | -21.94 | -81.14 |
Interest & Investment Income | 26.96 | 36.77 | 57.07 | 46.78 | 12.67 | 0.78 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.81 |
Other Non Operating Income (Expenses) | -2.29 | 10.37 | -6.04 | 4.45 | -0.86 | - |
EBT Excluding Unusual Items | -128.02 | -135.97 | -181.56 | -181.56 | -227.6 | -320.17 |
Merger & Restructuring Charges | -30.63 | -27.8 | -22.1 | -38.05 | -23.04 | -26.64 |
Impairment of Goodwill | - | -71.76 | -790 | - | -13,403 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 5.9 |
Asset Writedown | - | - | - | - | -9.9 | - |
Other Unusual Items | - | - | - | - | - | -43.75 |
Pretax Income | -158.65 | -235.53 | -993.65 | -219.61 | -13,663 | -384.66 |
Income Tax Expense | -3.83 | -35.21 | 7.59 | 0.76 | -3.81 | 44.14 |
Net Income | -154.82 | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 |
Net Income to Common | -154.82 | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 180 | 176 | 171 | 165 | 161 | 157 |
Shares Outstanding (Diluted) | 180 | 176 | 171 | 165 | 161 | 157 |
Shares Change | 2.87% | 3.32% | 3.64% | 1.93% | 2.88% | 73.40% |
EPS (Basic) | -0.86 | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 |
EPS (Diluted) | -0.86 | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 261.96 | 285.46 | 282.89 | 338.56 | 172.81 | 185.46 |
Free Cash Flow Per Share | 1.46 | 1.62 | 1.66 | 2.06 | 1.07 | 1.18 |
Gross Margin | 68.57% | 69.50% | 70.76% | 70.80% | 69.09% | 68.01% |
Operating Margin | -5.36% | -6.46% | -8.13% | -8.09% | -9.04% | -11.76% |
Profit Margin | -6.27% | -7.92% | -38.96% | -8.47% | -567.53% | -21.09% |
Free Cash Flow Margin | 10.61% | 11.28% | 11.01% | 13.01% | 7.18% | 9.12% |
EBITDA | 85.54 | 33.06 | 31.72 | 43.61 | -7.54 | -31.42 |
EBITDA Margin | 3.47% | 1.31% | 1.23% | 1.68% | -0.31% | -1.55% |
D&A For EBITDA | 217.87 | 196.46 | 240.51 | 254.11 | 209.93 | 207.57 |
EBIT | -132.33 | -163.4 | -208.79 | -210.5 | -217.47 | -238.99 |
EBIT Margin | -5.36% | -6.46% | -8.13% | -8.09% | -9.04% | -11.76% |
Advertising Expenses | - | 648.48 | 693.21 | 673.55 | 609.45 | 397.77 |